雷允上品牌怎么样 申请店铺

我要投票 雷允上在冬虫夏草行业中的票数:910 更新时间:2026-01-05
雷允上是哪个国家的品牌?「雷允上」是 雷允上药业集团有限公司 旗下著名品牌。该品牌发源于江苏,由创始人张邦国在1994期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力雷允上品牌出海!将品牌入驻外推网,定制雷允上品牌推广信息,可以显著提高雷允上产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

雷允上怎么样

吴门名医雷大升(1696--1779年)字允上,号南山,自幼读书习医,清康熙五十四年(1715年)弃儒从医。清雍正十二年(1734年),雷大升在苏州阊门内专诸巷天库前周王庙弄口,开设了诵芬堂老药铺,始创雷允上药业。雷大升著有《金匮辨证》、《要症方略》、《经病方论》、《丹丸方论》等典籍。由于医术高明,治病有方,于是“雷允上”名声遍闻苏州,蜚声杏林。

进入新世纪后,雷允上药业有限公司已发展成为集工业、商业和连锁为一体的大型医药集团企业,旗下包括现代中药制剂生产基地--常熟雷允上制药有限公司;商业流通企业--苏州雷允上商业有限公司;以及囊括了诵芬堂、王鸿翥、沐泰山等六家百年老店的连锁经营企业--苏州雷允上国药连锁总店有限公司;围绕“治末病”,注重功能化、系列化产品开发的健康养生专业企业--苏州雷允上健康养生有限公司;以满足社会大众医疗和亚健康消费群体需求,为广大患者提供一流的中医药医疗和保健服务企业--苏州雷允上吴门国医药馆。

近年来,公司收获了中华老字号、国家级非物质文化遗产、高新技术企业等诸多荣誉,2010年被收录为国家中医药堂四枚特种邮票之一。

如今,公司已完成“雷允上药业集团股份有限公司‘名称预核准,为今后雷允上上市奠定坚实基础,努力实现走上市融资,再投入新产品的研发之路,实现企业发展良性循环,翻开百年雷允上的历史新篇章!

Lei Dasheng (1696-1779), a famous doctor of Wumen, was named yunshang (Nanshan). He studied medicine as a child and abandoned Confucianism in 1715. In 1734, in the 12th year of Yongzheng reign of the Qing Dynasty, Lei Dasheng opened the old medicine shop of reciting the fragrance hall at the entrance of Wangmiao Temple of the Zhou Dynasty in tianku, a special lane in the gate of Suzhou, and started the pharmaceutical industry under leiyunshang pharmaceutical. Lei Dasheng is the author of "syndrome differentiation of the Golden Chamber", "general plan of critical diseases", "Treatise on the prescriptions of meridians and diseases", "Treatise on the prescriptions of danwan", etc. Because of its excellent medical skills and effective treatment, leiyunshang is famous in Suzhou and Xinglin. After entering the new century, leiyunshang Pharmaceutical Co., Ltd. has developed into a large-scale pharmaceutical group enterprise integrating industry, commerce and chain. Its subsidiaries include Changshu leiyunshang Pharmaceutical Co., Ltd., a modern production base of traditional Chinese medicine, Suzhou leiyunshang commercial limited company, and chain operation of six hundred year old stores, including shuofentang, Wang Hongzhu and Mu Taishan Suzhou leiyunshang national medicine chain store Co., Ltd. is an enterprise; Suzhou leiyunshang health care Co., Ltd., a professional health care enterprise focusing on functional and serial product development, focuses on "treating terminal diseases"; to meet the needs of the public medical and sub-health consumer groups and provide first-class TCM medical and health care services for the majority of patients -- wumenguo pharmaceutical under Suzhou leiyunshang Museum. In recent years, the company has won many honors such as Chinese time-honored brand, national intangible cultural heritage, high-tech enterprise, etc., and was included as one of the four special stamps of the national traditional Chinese medicine hall in 2010. Now, the company has completed the pre approval of the name of "leiyunshang Pharmaceutical Group Co., Ltd." to lay a solid foundation for the listing of leiyunshang Pharmaceutical Group Co., Ltd. in the future, and strive to take the road of listing financing, and then investing in the research and development of new products, to achieve a virtuous cycle of enterprise development, and to open a new chapter in the history of leiyunshang Pharmaceutical Group Co., Ltd!

本文链接: https://brand.waitui.com/94cf30fca.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

天赐材料:拟对龙山北基地年产15万吨液体六氟磷酸锂产线进行停产检修

36氪获悉,天赐材料公告,为保障后续液体六氟磷酸锂生产装置正常运行和安全稳定生产,公司拟对龙山北基地年产15万吨液体六氟磷酸锂产线进行停产检修,预计检修时间为20天至30天。公司已做好相关报批手续及材料准备,预计不会对公司经营情况造成较大影响。

2小时前

豪鹏科技:拟定增募资不超8亿元

36氪获悉,豪鹏科技公告,公司拟向特定对象发行股票募集资金不超过8亿元,扣除发行费用后的募集资金净额将用于储能电池建设项目和钢壳叠片锂电池建设项目。

2小时前

海致科技港股IPO获中国证监会备案

36氪获悉,证监会国际合作司发布北京海致科技集团股份有限公司境外发行上市及境内未上市股份“全流通”备案通知书,公司拟发行不超过47,584,600股境外上市普通股并在香港联合交易所上市。

2小时前

驭势科技港股IPO获中国证监会备案

36氪获悉,证监会国际合作司发布驭势科技(北京)股份有限公司境外发行上市及境内未上市股份“全流通”备案通知书,公司拟发行不超过18,914,150股境外上市普通股并在香港联合交易所上市。

2小时前

德适生物港股IPO获中国证监会备案

36氪获悉,证监会国际合作司发布杭州德适生物科技股份有限公司境外发行上市及境内未上市股份“全流通”备案通知书,公司拟发行不超过31,004,000股境外上市普通股并在香港联合交易所上市。

2小时前

本页详细列出关于雷允上的品牌信息,含品牌所属公司介绍,雷允上所处行业的品牌地位及优势。
咨询